Clinical Trial Update: Vytorin (10/20 Or 10/40) Compared to Atorvastatin (10 mg or 20 mg) in Patients With Coronary Artery Disease (0653A-126)(COMPLETED) [Phase 4]

View source ↗

Summary

This completed Phase 4 trial compared Vytorin (ezetimibe/simvastatin) versus atorvastatin in patients with coronary artery disease and hypercholesterolemia, wit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Hypercholesterolemia

Drugs mentioned

• Vytorin (ezetimibe/simvastatin)
• atorvastatin (atorvastatin)

Snippet

Sponsor: Organon and Co | Conditions: Hypercholesterolemia | Phase 4 | Status: COMPLETED | Results posted: 2009-11-09